ESR1, PGR, ERBB2, and MKi67 mRNA expression in diagnostic core biopsies from breast cancer patients of the ABCSG Trial 34
Stephanie Strobl, Martin Filipits(University of Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Angelika Pichler, Michael Gnant(Austrian Breast & Colorectal Cancer Study Group), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern), Christine Deutschmann(Universitätsklinik für Frauenheilkunde und Geburtshilfe), Rupert Bartsch(Universitätszahnklinik Wien), Farid Moinfar(AGO Austria), Jodi Weidler, Karl Sotlar(University of Tübingen), Sigurd Lax(Graz University Hospital), Michael Bates, Peter Dubsky(Hirslanden Klinik St. Anna), Gabriel Rinnerthaler(Medical University of Graz), Daniel Egle(Innsbruck Medical University), Edgar Petru(Medical University of Graz), Dominik Hlauschek(Austrian Breast & Colorectal Cancer Study Group), Christian F. Singer(Medical University of Vienna), Richard Greil(Paracelsus Medical University)
Cited by 1
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k